Olanzapine
Who holds supplier records for Olanzapine? 26 organisations hold a current record for Olanzapine: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 20 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (18), China (3), Canada (1), Netherlands (1) and 1 other country (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Olanzapine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/olanzapine
Reading the evidence
- 26 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
18 of the 24 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 17 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Olanzapine expires 10 Jan 2044. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (26)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Olanzapine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 29789, 23525 · latest filing Sept 2015
- Apotex Inc.CanadaActive DMF 29444, 21980 · latest filing Jun 2015
- CHROMO LABORATORIES INDIA PRIVATE LTDIndiaCEPActive DMF 33221 · latest filing Jul 2022
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 15299 · latest filing Feb 2001
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 20591 · latest filing Jun 2007
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 37101 · latest filing Jul 2022
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 30352 · latest filing Mar 2016
- LEE PHARMA LTDIndiaCEP Company GMP cert on recordActive DMF 39150 · latest filing Dec 2023
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 24333 · latest filing Oct 2010
- Qilu Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 25175 · latest filing Jul 2011
- SOLARA ACTIVE PHARMA SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 18260 · latest filing Apr 2005
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordActive DMF 21506 · latest filing Mar 2008
- TAPI NL BVNetherlandsCEPActive DMF 20218 · latest filing Jan 2007
- Torrent PharmaceuticalsIndiaCEP Company GMP cert on recordActive DMF 22555 · latest filing Feb 2009
- Alkem Laboratories LimitedIndia Company GMP cert on recordActive DMF 24016, 43881 · latest filing Mar 2026
- HEC PHARM COChinaCEP Company GMP cert on recordActive DMF 26763 · latest filing Dec 2012
- INKE SASpainActive DMF 26694 · latest filing Jan 2013
- JUBILANT PHARMOVA LTDIndiaActive DMF 20990 · latest filing Oct 2007
- ORBION PHARMACEUTICALS PRIVATE LTDIndia Company GMP cert on recordActive DMF 24020 · latest filing Aug 2010
- ZHEJIANG SYNCOTIDE BIO-PHARMACEUTICAL CO LTDCEPActive DMF 23597 · latest filing Feb 2010
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 26072 · latest filing Jul 2012
- IndiaCEP Company GMP cert on record
- IndiaCEP
- NOSCH LABS PRIVATE LTDCEP Company GMP cert on record
- IndiaCEP
- Zhejiang Supor Pharmaceuticals Co., LtdChinaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (20)
Certificates of Suitability on the EDQM register for Olanzapine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 32 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHEJIANG SYNCOTIDE BIO-PHARMACEUTICAL CO., LTD. Shaoxing | CN | CEP 2019-182 - Rev 03 Olanzapine | Oct 2026 | Inspected Oct 2024 Belgium |
| NOSCH LABS PRIVATE LIMITED Hyderabad | IN | CEP 2024-382 - Rev 01 Olanzapine, Form-I | Sept 2026 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2024-297 - Rev 02 Olanzapine, Form II, micronised | Jun 2026 | — |
| HEC PHARM GMBH Berlin | DE | CEP 2012-406 - Rev 02 Olanzapine | Jun 2026 | — |
| TORRENT PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2013-177 - Rev 05 Olanzapine | Mar 2026 | — |
| LEE PHARMA LIMITED Hyderabad | IN | CEP 2017-020 - Rev 01 Olanzapine, Form-I | Mar 2026 | — |
| CADILA PHARMACEUTICALS LIMITED Ankleshwar | IN | CEP 2024-469 - Rev 00 Olanzapine, Form-I, Micronised | Dec 2025 | — |
| QILU PHARMACEUTICAL CO., LTD. Jinan | CN | CEP 2012-191 - Rev 03 Olanzapine, Form-II | Oct 2025 | Inspected Feb 2025 Switzerland |
| JUBILANT BIOSYS LIMITED Nanjangud | IN | CEP 2011-030 - Rev 02 Olanzapine | Sept 2025 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | CEP 2018-111 - Rev 01 Olanzapine | Aug 2025 | — |
| SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai | IN | CEP 2012-050 - Rev 04 Olanzapine | Jul 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2025-203 - Rev 00 Olanzapine, Micronised (Form-II), RX Code | Jul 2025 | — |
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2012-190 - Rev 02 Olanzapine, Form-1 | May 2025 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2011-392 - Rev 03 Olanzapine, Form-I | Nov 2024 | — |
| RAMPEX LABS PRIVATE LIMITED Anakapalli | IN | CEP 2024-287 - Rev 00 Olanzapine, Process-B | Nov 2024 | — |
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 2022-156 - Rev 00 Olanzapine | May 2024 | — |
| CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram | IN | R0-CEP 2019-304 - Rev 00 Olanzapine | Jan 2023 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | R0-CEP 2022-126 - Rev 00 Olanzapine, Form-I, Process II | Jun 2022 | — |
| RAMPEX LABS PVT. LTD. Parawada Village | IN | R1-CEP 2015-238 - Rev 00 Olanzapine | Mar 2022 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | R1-CEP 2012-300 - Rev 01 Olanzapine | Feb 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (10)
Organisations whose Type II DMFs for Olanzapine are no longer active. These show a past filing, not current supply.
Show all 10 historical records
- China · Inactive DMF 30041 · filed Jan 2016
- India · Inactive DMF 15052, 29063 · filed May 2015
- Kyongbo Pharmaceutical Co., Ltd.South · Inactive DMF 28976 · filed Jan 2015
- China · Inactive DMF 27219 · filed Jul 2013
- JIANGSU HANSOH PHARMACEUTICAL CO LTDInactive DMF 24480 · filed Dec 2010
- RANBAXY LABORATORIES LTDInactive DMF 21947 · filed Sept 2008
- Slovenia · Inactive DMF 20354 · filed Mar 2007
- India · Inactive DMF 19168 · filed Feb 2006
- MYLAN LABORATORIES LTDInactive DMF 18867 · filed Oct 2005
- VENKAT PHARMA LTDInactive DMF 18108 · filed Feb 2005
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (145 listed products contain Olanzapine). The latest listed patent expires 10 Jan 2044. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Olanzapine is an atypical antipsychotic used in the treatment of schizophrenia and bipolar disorder. It works by rebalancing dopamine and serotonin to improve thinking, mood, and behaviour.
Chemical identity
- IUPAC name
- 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
- Canonical SMILES
- CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C
- InChIKey
- KVWDHTXUZHCGIO-UHFFFAOYSA-N
- Synonyms
- Zyprexa API, olanzapine, Olansek, Zalasta, Zyprexa Zydis, Zyprexa Velotab, Zyprexa Intramuscular, olanzapina, Olanzapine Mylan, LY-170053, Olazax, Olanzapine Teva
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Atypical Antipsychotic
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Olanzapine?
26 organisations hold an active US FDA Type II Drug Master File or a CEP for Olanzapine: APITORIA PHARMA PRIVATE LTD (India), Apotex Inc. (Canada), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Dr. Reddy's Laboratories Ltd. (India), Hetero Drugs Limited (India), Ipca Laboratories Limited (India), JUBILANT BIOSYS LTD (India) and LEE PHARMA LTD (India), and 18 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Olanzapine Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 29789, 23525), Apotex Inc. (DMF 29444, 21980), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 33221), Dr. Reddy's Laboratories Ltd. (DMF 15299), Hetero Drugs Limited (DMF 20591), Ipca Laboratories Limited (DMF 37101), JUBILANT BIOSYS LTD (DMF 30352) and LEE PHARMA LTD (DMF 39150) and 13 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Olanzapine records mean?
10 organisations have only inactive Type II DMFs for Olanzapine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Olanzapine have a European Certificate of Suitability?
Yes. 20 organisations hold a valid CEP for Olanzapine on the EDQM register, including ZHEJIANG SYNCOTIDE BIO-PHARMACEUTICAL CO., LTD. Shaoxing (CN), NOSCH LABS PRIVATE LIMITED Hyderabad (IN), TAPI NL B.V. Amsterdam (NL), HEC PHARM GMBH Berlin (DE), TORRENT PHARMACEUTICALS LIMITED Ahmedabad (IN) and LEE PHARMA LIMITED Hyderabad (IN) and 14 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Olanzapine?
Yes. The latest patent listed for an approved US product containing Olanzapine expires 10 Jan 2044, across 145 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Olanzapine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Olanzapine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.